August 23, 2021

How to cast a smarter net

Taking a new approach to expert identification can reshape outcomes for life science teams.
KOL selection

For many pharmaceutical and medical device teams, KOL selection can go one of two ways: defaulting to the list of KOLs they always use or outsourcing the work to a third party. Problem is, there are drawbacks to both approaches. Going back to the same people over and over again lets you talk to the experts you know best – but they might not be the best people to provide insight on every topic or therapeutic area. And hiring a third party can be time-consuming and expensive.

Related Posts:

life science challenges and opportunities

The shark and the goldfish

What should life science companies look out for in the year ahead? What opportunities should industry leaders pursue?
what is an insight

What is an insight?

The difference between information and insights is distinct and increasingly important to life science leaders.
pharma compliance software

A guide to pharma industry compliance software

With countless compliance solutions, why should pharma companies consider insights management technology?